Imaging assessment after SBRT for hepatocellular carcinoma

Connie Yip; Tiffany Priyanthi Hennedige; Gary J.R. Cook; Vicky Goh

doi:10.20517/2394-5079.2020.30

Imaging assessment after SBRT for hepatocellular carcinoma

Connie Yip^*, Tiffany Priyanthi Hennedige, Gary J.R. Cook, Vicky Goh

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Abstract

The use of stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) has increased over the past few decades. Thus, accurate evaluation of post-SBRT treatment response is essential to avoid over-treatment of responders as well as missing the opportunity to salvage non-responders. There are some intricate imaging differences after liver SBRT compared to those observed after conventional fractionated radiotherapy and other locoregional treatment. We aim to review the imaging changes that occur following SBRT for HCC and their potential clinical implications.

Original language	English
Journal	Hepatoma Research
Volume	6
DOIs	https://doi.org/10.20517/2394-5079.2020.30
Publication status	Published - 2020

Keywords

Hepatocellular carcinoma
Imaging
Liver
Stereotactic body radiotherapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.20517/2394-5079.2020.30

Cite this

@article{edd9cff283f14c32b950c2927957766a,

title = "Imaging assessment after SBRT for hepatocellular carcinoma",

abstract = "The use of stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) has increased over the past few decades. Thus, accurate evaluation of post-SBRT treatment response is essential to avoid over-treatment of responders as well as missing the opportunity to salvage non-responders. There are some intricate imaging differences after liver SBRT compared to those observed after conventional fractionated radiotherapy and other locoregional treatment. We aim to review the imaging changes that occur following SBRT for HCC and their potential clinical implications.",

keywords = "Hepatocellular carcinoma, Imaging, Liver, Stereotactic body radiotherapy",

author = "Connie Yip and Hennedige, {Tiffany Priyanthi} and Cook, {Gary J.R.} and Vicky Goh",

year = "2020",

doi = "10.20517/2394-5079.2020.30",

language = "English",

volume = "6",

journal = "Hepatoma Research",

issn = "2394-5079",

publisher = "OAE Publishing Inc.",

}

TY - JOUR

T1 - Imaging assessment after SBRT for hepatocellular carcinoma

AU - Yip, Connie

AU - Hennedige, Tiffany Priyanthi

AU - Cook, Gary J.R.

AU - Goh, Vicky

PY - 2020

Y1 - 2020

N2 - The use of stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) has increased over the past few decades. Thus, accurate evaluation of post-SBRT treatment response is essential to avoid over-treatment of responders as well as missing the opportunity to salvage non-responders. There are some intricate imaging differences after liver SBRT compared to those observed after conventional fractionated radiotherapy and other locoregional treatment. We aim to review the imaging changes that occur following SBRT for HCC and their potential clinical implications.

AB - The use of stereotactic body radiotherapy (SBRT) in hepatocellular carcinoma (HCC) has increased over the past few decades. Thus, accurate evaluation of post-SBRT treatment response is essential to avoid over-treatment of responders as well as missing the opportunity to salvage non-responders. There are some intricate imaging differences after liver SBRT compared to those observed after conventional fractionated radiotherapy and other locoregional treatment. We aim to review the imaging changes that occur following SBRT for HCC and their potential clinical implications.

KW - Hepatocellular carcinoma

KW - Imaging

KW - Liver

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85118303001&partnerID=8YFLogxK

U2 - 10.20517/2394-5079.2020.30

DO - 10.20517/2394-5079.2020.30

M3 - Review article

AN - SCOPUS:85118303001

SN - 2394-5079

VL - 6

JO - Hepatoma Research

JF - Hepatoma Research

ER -

Imaging assessment after SBRT for hepatocellular carcinoma

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this